Antibody treatment for Covid trialled on NHS is found to prevent 100% of symptomatic infections
An experimental coronavirus drug which is now being trialled on the NHS has been found to cause a 100 per cent reduction in symptomatic infections and also reduce overall infection rates. Regeneron Pharmaceuticals Inc said on Tuesday that its two-antibody cocktail REGEN-COV prevented 100 per cent of the 186 people who got the drug after being … Read more